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Abstract 
Human papillomavirus (HPV) infection is one of the most prevalent sexually transmitted diseases among women 
aged < 35 years worldwide. Recent studies have suggested that the vaginal microenvironment influenced by 
bacterial infection poses for high-risk human papillomavirus (hrHPV) infection and cervical carcinogenesis. 
Female sex workers (FSWs) are a population susceptible to acquire Human Immunodeficiency Virus (HIV) and 
sexually transmitted infections (STIs), as well as transmitting the virus to others. The aim of this study is to 
evaluate the relationship between Mycoplasma/Ureaplasma infections and HPV infection among female sex 
workers. A total of 70 female sex workers of reproductive age were recruited from various location in Medan, 
Indonesia in 2018. Detection of Mycoplasma/Ureaplasma infections and HPV infection were obtained from PCR 
assessment. The results of this study showed that no correlation significant between Mycoplasma 
hominis/Ureaplasma urealyticum infection and HPV infection. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Human papillomavirus (HPV) has been 
identified as an essential aetiology of warts, cervical 
intraepithelial neoplasia (CIN) and cervical cancer [1]. 
Among high-risk HPV, type 16 and 18 are the most 
carcinogenic for the progression of cervical disease 
and induce over 70% of cervical cancer, stated as the 
second most common cancer in women as reported in 
2012 by the International Agency for Research on 
Cancer (IARC) [2]. The cervical cancer death currently 
accounted for about 57% of cases and 65% of cancer 
deaths worldwide [3], [4]. De Boer previously have 
stated that no information existed about the 
prevalence of HPV 18 or other HPV types in the 
Indonesian population and hypothesised that the high 
prevalence of HPV 18 in cervical cancer in Indonesia 
is caused by the high prevalence of HPV 18 in the 
Indonesian population [5]. The estimated incidence of 
cervical cancer in Indonesia is 17 per 100,000 women 
[6]. 
Beside persistent infection and an increase in 
viral load of HPV infection, other concomitant 
infections are also known risk factors causing rapid 
development of cervical cancer, while the negative 
contribution of smoking and contraceptive medication 
act as environmental risk factors [7]. Risk factors 
associated with cervical cancer include first 
intercourse at an early age, mutually change sexual 
partners, and suffering from chronic sexually 
transmitted infections (STIs) other than HPV and HIV 
[8], [9], [10]. 
Association between HPV infection with 
cervical cancer has been already known, even though 
several studies found Mycoplasma hominis and 
Ureaplasma urealyticum involvement contribute to the 
risk of HPV infection and the occurrence of abnormal 
cervical cytology [11], [12]. These bacterias were 
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found in 30 ± 80% women’s urogenital tract as a 
commensal organism but had the pathogenic potential 
[13]. Several studies revealed that Mycoplasma 
hominis and Ureaplasma urealyticum played a role in 
developing abnormal cervical cytology associated with 
the development of precancerous cervical lesions [7]. 
Mycoplasma/Ureaplasma infections can cause 
chronic pelvic pain if the infection infiltrates the pelvis 
or genitourinary system. Persistent or untreated 
chronic infection can lead to cervical cancer in 
addition to pelvic pain, by causing persistent HPV 
infection or increased HPV levels [14]. 
Female sex workers (FSWs) are commonly 
known very vulnerable to exposure to HIV and 
sexually transmitted infections (STIs), as well as 
transmitting the virus or bacterias to others, due to 
behavioural risk factors as recurrent infections and 
repeated contact through high numbers of sexual 
partners [15]. This is compounded by the lack of 
knowledge and awareness of HPV infection, cervical 
cancer, and preventive efforts, as previously 
described in several studies [16], [17]. 
This study aims to evaluate the relationship 
between Mycoplasma/Ureaplasma infections and 
HPV infection among female sex workers in Medan, 
Indonesia. 
 
 
Material and Methods 
 
Study Population 
 This study is a descriptive study with a cross-
sectional design to evaluate the relationship between 
Mycoplasma hominis and Ureaplasma urealyticum 
infection and HPV infection among female sex 
workers. A total of 70 female sex workers of 
reproductive age were recruited from various location 
in Medan, North Sumatera, Indonesia, between July 
and September 2018.  
 Subjects were women aged between 18 and 
above who were sexually active. Exclusion criteria 
were subjects recently diagnosed with the cervical 
disease within 6 months before the present study and 
currently pregnant. All participants were interviewed to 
collect information on socio-demographic background. 
The Ethics Committee of the University of Sumatera 
Utara approved the study, and informed consent 
forms were obtained from all subjects.  
 
  
 Detection of HPV and 
 Mycoplasma/Ureaplasma 
 DNA samples were isolated from cervical 
swabs using Presto
n 
Buccal Swab gDNA extraction 
kit.DNA was then amplified using the established PCR 
method. PCR kit components used for HPV gene 
amplification were DNA template of 6 μl, GoTaq® 
Green Master Mix (Promega) of 12.5 μl, a primer of 
forwarding HPV. Mycoplasma hominis and 
Ureaplasma urealyticum used 2 primers: RNAH1 and 
RNAH2 that amplify the 16sRNA Mycoplasma hominis 
gene at 334 bp; UMS125 and UMA226 amplified 
Ureaplasma urealyticum serovar 3 which shows 
multiple bands at 403 bp for biovar 1 and 448 bp for 
biovar 2. The amplification mixture was carried out in 
12.5 l master mix PCR consisted of Taq polymerase 
enzyme, MgSO4, and dNTP(Go Taq® PCR Core 
System, Promega). 
 
 
Results 
 
The data summarised in Table 1 showed the 
distribution of age according to the infection of 
Mycoplasma hominis/Ureaplasma urealyticum and 
HPV. This study showed that HPV 16 infection was 
higher in women aged 26-30 (12.5%), while that HPV 
18 infection was found higher in women aged 18-25 
(26.9%). The occurrence of Mycoplasma infections 
was more common in the age group 18-25 (31.4%), 
while Ureaplasma infections were more prevalent in 
the age group 31-45 (60.9%). 
Table 1: Distribution of age by infection of Mycoplasma 
hominis/ Ureaplasma urealyticum and HPV 
Infection 
 
Total 
N = 70 
Age in years 
18-25 
N = 26 
(37.1%) 
26-30 
N = 16 
(22.9%) 
31-45 
N = 23 
(32.9%) 
> 45 
N = 5 
(7.1%) 
HPV16 (+) 
HPV16 (-) 
HPV18 (+) 
HPV18 (-) 
Mycoplasma (+) 
Mycoplasma (-) 
Ureaplasma (+) 
Ureaplasma (-) 
3(4.3) 
67(95.7) 
13(18.6) 
57(81.4) 
22(31.4) 
48(68.6) 
32(45.7) 
38(54.3) 
1(3.8) 
25(96.2) 
7(26.9) 
19(73.1) 
11(42.3) 
15(57.7) 
9(34.6) 
17(65.4) 
2(12.5) 
14(87.5) 
3(18.8) 
13(81.3) 
5(31.3) 
11(68.8) 
6(37.5) 
10(62.5) 
0(0) 
23(100) 
3(13.0) 
20(87.0) 
6(26.1) 
17(73.9) 
14(60.9) 
9(39.1) 
0(0) 
5(100) 
0(0) 
5(100) 
0(0) 
5(100) 
3(60.0) 
2(40.0) 
 
The previous study found that infections of C. 
trachomatis, M. genitalicum, and U. parvum were 
higher in the younger age group by comparisons 
based on age (< 50 years vs ≥ 50 years) [10]. Similar 
to the previous study, the respondents of this study 
mostly younger than 50 years, and bacterial infections 
more often to occur in the age group 18-25 years and 
31-45 years. 
Another study found that HPV infection peak 
in women aged 40-50 years [18]. Different from the 
results of the former study, HPV 16 infections were 
higher in women aged 26-30 years, while HPV 18 
found high in women aged 18-25 years. Nevertheless, 
another study showed no correlation between HPV 
infection and the age of the respondent, and also 
found that age was not related to abnormal cytology 
or bacterial infection [19]. 
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Table 2: Relationship between Mycoplasma hominis and 
Ureaplasma urealyticum infection and HPV infection 
Bacterial 
infection 
HPV 16 infection 
OR 
P-
value 
CI 
95% 
HPV 18 infection 
OR 
P-
value 
CI 
95% Positive Negative Positive Negative 
Mh 
Positive 
Negative 
 
0 (0,0%) 
3 
(100,0%) 
 
22 (32,8%) 
45 (67,2%) 
 
- 
 
0.547
a 
 
- 
 
3 (23,1%) 
10 
(76,9%) 
 
19 (33,3%) 
38 (66,7%) 
 
0.6 
 
0.742
a 
 
0.148- 
2.440 
Uu 
Positive 
Negative 
2 (66,7%) 
1 (33,3%) 
30 (44,8%) 
37 (55,2%) 
2.426 0.589
a 
 
0.213- 
28.535 
6 (46,2%) 
7 (53,8%) 
26 (45,6%) 
31 (54,4%) 
1.0
22 
1.000
a 0.305- 
3.422 
 
 
The results of this study as shown in Table 2, 
found that no correlation between Mycoplasma 
hominis infection with HPV 16 infection (p = 0.547) 
and neither with HPV 18 infection (p = 0.742). There 
were no correlation as well between Ureaplasma 
urealyticum infection with HPV 16 infection (p = 
0.580), and also no correlation with HPV 18 infection 
(p = 0.639). 
 
 
Discussion 
 
The results were different from previous 
studies that found a significant association between 
HPV infection and the presence of 
Mycoplasma/Ureaplasma infection [11], [18]. Another 
study showed the correlation not only between 
bacterial infection and high-risk HPV infection but also 
between abnormal cytology with bacterial infection 
[10]. Another previous study from Korea from 
asymptomatic women of reproductive age with 
negative cytologic findings found that most HPV 
infections were not correlated with any specific STIs 
[20]. Another study from Estonia found the high risk-
HPV was associated with STIs especially Chlamydia 
infection, and also with U. urealyticum infection in 
women over 41 years old. The same study found that 
U. urealyticum infection was not associated with HPV 
status [21]. A study from Nigeria found significant 
associations between persistent high-risk HPV 
infections and persistent M. Hominis in the vaginal 
microbiota, and the study suggested that M. Hominis 
may play a role in high-risk HPV induced cervical 
carcinogenesis [22]. 
Several studies showed that a high density of 
Ureaplasma might be associated with STIs and the 
differentiation of colonisation and infection contributed 
to co-infection, as reported by Kim et al., that showed 
only Ureaplasma colonization with greater than 104 
CCU/mL was significantly associated with HPV 
infection [19]. Another study which in line showed 
patients with cervical lesions had higher U. parvum 
load colony-forming unit [23]. Unfortunately, in this 
study, we did not assess the bacterial load of 
Ureaplasma and Mycoplasma. The correlation 
between colonies number and infection may be 
explained by more pathogen colony could develop 
more cervical lesion as well due to chronic infections 
by activating the virulence factor. Few studies have 
been conducted to evaluate the association between 
ureaplasma load with cervical disorders especially 
with precursor cervical lesions of cervical cancer [5]. 
In conclusion, this study revealed that there is 
no significant correlation between the presence of 
Mycoplasma hominis/Ureaplasma urealyticum 
infection and HPV infection. Although among female 
sex workers, sexually transmitted infections like 
Mycoplasma spp, and Ureaplasma spp were 
frequently detected and as well as the HPV infection. 
However, this non-significant result might be due to 
the limitation of this study. We only recruited a small 
number of samples and therefore could not provide 
confirmed statistical significance for all of the tests 
performed. 
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